Cresco Labs OTC (TSE:CL) has released an update.
Cresco Labs Inc. has announced its Q1 2024 financial results, showing robust financial health with a remarkable tenfold increase in operating cash flow year-over-year. Despite flat revenue growth when excluding strategic divestitures, the company has made significant strides in profitability with a 7% increase in adjusted gross profit and substantial improvements in EBITDA margins. The company continues to dominate market shares in key states and looks forward to upcoming growth opportunities with legislative changes.
For further insights into TSE:CL stock, check out TipRanks’ Stock Analysis page.
